Allspring Global Investments Holdings LLC Grows Position in NextGen Healthcare, Inc. (NASDAQ:NXGN)

Allspring Global Investments Holdings LLC lifted its holdings in NextGen Healthcare, Inc. (NASDAQ:NXGNGet Rating) by 25.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,067 shares of the company’s stock after buying an additional 5,456 shares during the period. Allspring Global Investments Holdings LLC’s holdings in NextGen Healthcare were worth $479,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Clearstead Advisors LLC acquired a new position in shares of NextGen Healthcare during the 2nd quarter worth approximately $26,000. First Horizon Advisors Inc. grew its holdings in NextGen Healthcare by 33.0% in the 2nd quarter. First Horizon Advisors Inc. now owns 3,784 shares of the company’s stock valued at $66,000 after buying an additional 939 shares in the last quarter. Captrust Financial Advisors increased its stake in shares of NextGen Healthcare by 61.5% in the 1st quarter. Captrust Financial Advisors now owns 4,255 shares of the company’s stock worth $89,000 after acquiring an additional 1,620 shares during the last quarter. Truvestments Capital LLC acquired a new position in shares of NextGen Healthcare during the 2nd quarter valued at about $77,000. Finally, KBC Group NV purchased a new stake in shares of NextGen Healthcare in the second quarter valued at about $82,000. 73.70% of the stock is currently owned by institutional investors and hedge funds.

NextGen Healthcare Stock Down 1.0 %

Shares of NASDAQ NXGN opened at $17.28 on Tuesday. The business’s 50 day moving average is $18.99 and its two-hundred day moving average is $18.29. NextGen Healthcare, Inc. has a 52-week low of $16.13 and a 52-week high of $21.99. The firm has a market cap of $1.17 billion, a price-to-earnings ratio of 55.74 and a beta of 1.02.

NextGen Healthcare (NASDAQ:NXGNGet Rating) last posted its quarterly earnings data on Tuesday, October 25th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.02). NextGen Healthcare had a net margin of 3.31% and a return on equity of 6.50%. The firm had revenue of $159.44 million during the quarter, compared to analysts’ expectations of $156.46 million. Analysts anticipate that NextGen Healthcare, Inc. will post 0.58 EPS for the current fiscal year.

Insider Transactions at NextGen Healthcare

In related news, CTO David A. Metcalfe sold 32,372 shares of NextGen Healthcare stock in a transaction that occurred on Wednesday, October 26th. The shares were sold at an average price of $20.21, for a total value of $654,238.12. Following the completion of the transaction, the chief technology officer now owns 148,776 shares in the company, valued at $3,006,762.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other NextGen Healthcare news, CTO David A. Metcalfe sold 32,372 shares of the business’s stock in a transaction on Wednesday, October 26th. The shares were sold at an average price of $20.21, for a total value of $654,238.12. Following the completion of the transaction, the chief technology officer now owns 148,776 shares in the company, valued at $3,006,762.96. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Mitchell Waters sold 9,783 shares of the company’s stock in a transaction on Tuesday, November 8th. The stock was sold at an average price of $20.50, for a total value of $200,551.50. Following the sale, the executive vice president now directly owns 70,469 shares in the company, valued at approximately $1,444,614.50. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 110,788 shares of company stock valued at $2,246,225. 4.50% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. TheStreet upgraded shares of NextGen Healthcare from a “c” rating to a “b-” rating in a report on Wednesday, October 26th. SVB Leerink raised their target price on NextGen Healthcare from $24.00 to $25.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 26th. Piper Sandler reaffirmed a “neutral” rating and issued a $20.00 price target on shares of NextGen Healthcare in a research note on Friday, October 21st. Finally, StockNews.com cut NextGen Healthcare from a “strong-buy” rating to a “buy” rating in a report on Friday. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $22.75.

NextGen Healthcare Profile

(Get Rating)

NextGen Healthcare, Inc provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions.

See Also

Want to see what other hedge funds are holding NXGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NextGen Healthcare, Inc. (NASDAQ:NXGNGet Rating).

Institutional Ownership by Quarter for NextGen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.